Literature DB >> 30729731

Validation of algorithms to identify knee osteoarthritis patients in the claims database.

Ha-Rim Park1, SeulGi Im2, Hyoungyoung Kim1, Sun-Young Jung3, Dalho Kim2, Eun Jin Jang4, Yoon-Kyoung Sung1, Soo-Kyung Cho1.   

Abstract

BACKGROUND: To identify knee osteoarthritis (OA) patients among OA patients in the claims database.
METHODS: All patients with OA diagnostic codes for any sites (M15 to M19) in 2014 were recruited from a single academic referral hospital. After excluding patients who had inflammatory arthritis or were less than 50 years of age, we identified data for the overall OA population. Radiographic knee OA of Kellgren and Lawrence grades ≥2 is considered the gold standard for knee OA, and we evaluated the sensitivity, specificity, and positive predictive value (PPV) of three operational definitions using the diagnostic codes in the claims database. The operational definitions were: (1) gonarthrosis (M17); (2) any site of OA (M15 to M19) with knee X-ray; and (3) (1) or (2).
RESULTS: A total of 7959 OA patients were included in this study of whom 74.5% were women. The PPV of gonarthrosis (M17) was 0.67 (95% CI 0.65-0.69), and sensitivity was 0.44 (95% CI 0.42-0.46). The PPV and sensitivity of any OA site (M15 to M19) with knee X-ray were 0.65 (95% CI 0.62-0.67), and 0.37 (95% CI 0.35-0.39), respectively. When knee OA was defined as satisfying either of the two above definitions, PPV was 0.63 (95% CI 0.62-0.65) and sensitivity 0.55 (95% CI 0.53-0.57).
CONCLUSIONS: Knee OA patients can be identified in a claims database using the algorithms of gonarthrosis (M17) or any site of OA (M15 to M19) with a performed knee X-ray.
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  claims data; diagnostic codes; osteoarthritis; validation

Mesh:

Year:  2019        PMID: 30729731     DOI: 10.1111/1756-185X.13470

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  6 in total

1.  Validity of operative information in Japanese administrative data: a chart review-based analysis of 1221 cases at a single institution.

Authors:  Takaaki Konishi; Takako Yoshimoto; Michimasa Fujiogi; Hayato Yamana; Masahiko Tanabe; Yasuyuki Seto; Hideo Yasunaga
Journal:  Surg Today       Date:  2022-05-12       Impact factor: 2.540

2.  COX-2 Inhibitor Use as an Early Treatment Option for Knee Osteoarthritis Patients in Korea: A Population-Based Cross-Sectional Study.

Authors:  Eun Jin Jang; Yoon-Kyoung Sung; Soo-Kyung Cho; Seongmi Choi; Hyoungyoung Kim; Yeo-Jin Song; Sun-Young Jung
Journal:  J Korean Med Sci       Date:  2022-05-09       Impact factor: 5.354

3.  Wireless Motion Sensors-Useful in Assessing the Effectiveness of Physiotherapeutic Methods Used in Patients with Knee Osteoarthritis-Preliminary Report.

Authors:  Jagoda Goślińska; Agnieszka Wareńczak; Margaret Miedzyblocki; Krystyna Hejdysz; Ewa Adamczyk; Paweł Sip; Ewa Chlebuś; Jarosław Gośliński; Piotr Owczarek; Adam Woźniak; Przemysław Lisiński
Journal:  Sensors (Basel)       Date:  2020-04-16       Impact factor: 3.576

4.  Factors related to the use of opioids as early treatment in patients with knee osteoarthritis.

Authors:  Soo-Kyung Cho; Sun-Young Jung; Seongmi Choi; Seul Gi Im; Hyoungyoung Kim; Woo Seok Choi; Eun Jin Jang; Yoon-Kyoung Sung
Journal:  Arthritis Res Ther       Date:  2019-11-04       Impact factor: 5.156

5.  Prevalence of Sleep Disturbance and Its Risk Factors in Patients Who Undergo Surgical Treatment for Degenerative Spinal Disease: A Nationwide Study of 106,837 Patients.

Authors:  Jihye Kim; Min Seong Kang; Tae-Hwan Kim
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

6.  Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review.

Authors:  Anaïs Lacasse; Elizabeth Cauvier Charest; Roxanne Dault; Anne-Marie Cloutier; Manon Choinière; Lucie Blais; Alain Vanasse
Journal:  Pain Med       Date:  2020-09-01       Impact factor: 3.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.